Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report)’s share price fell 5% on Thursday following a weaker than expected earnings announcement. The company traded as low as $21.71 and last traded at $21.38 ...
The tally of suspected Guillain-Barré syndrome (GBS) cases in the Pune region has reached 180, with the detection of seven ...
Mumbai reported its first case of Guillain-Barré syndrome on Friday after a 64-year-old woman was diagnosed with the rare ...
SG Americas Securities LLC increased its position in argenx SE (NASDAQ:ARGX – Free Report) by 6.2% in the 4th quarter, ...